Related Experiment Video
Updated: May 1, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
The impact of antifungals on toll-like receptors
Mircea R Mihu1, Rodney Pattabhi1, Joshua D Nosanchuk2
1Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine-Montefiore Medical Center Bronx, NY, USA.
Abstract:
Fungi are increasingly recognized as major pathogens in immunocompromised individuals. With the increase in the number of fungal infections each year and the development of resistance to current therapy, new approaches to treatment including stimulation of the immune response in addition to concurrent pharmacotherapy is ongoing. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp., and Cryptococcus spp. Amphotericin B (AmB) has remained the cornerstone of therapy against many fulminant fungal infections but its use is limited by its multitude of side effects. Echinocandins are a newer class of antifungal drugs with activity against Candida spp. and Aspergillus spp. and constitutes an alternative to AmB due to superior patient tolerability and fewer side effects. Due to their oral delivery, azoles continue to be heavily used for simple and complex diseases, such as fluconazole for candidal vaginitis and voriconazole for aspergillosis. The objective of this paper is to present current knowledge regarding the multiple interactions between the broad spectrum antifungals and the innate immune response, primarily focusing on the toll-like receptors.
Insights
Fungal infections are rising in immunocompromised patients, prompting research into new treatments. This study explores how antifungal drugs interact with the innate immune system, focusing on toll-like receptors.
Area of Science:
- Mycology
- Immunology
- Pharmacology
Background:
- Fungal infections pose a significant threat to immunocompromised individuals.
- Rising antifungal resistance necessitates novel therapeutic strategies.
- Common invasive fungi include Candida, Aspergillus, and Cryptococcus species.
Purpose of the Study:
- To review current knowledge on the interactions between broad-spectrum antifungal agents and the innate immune response.
- To specifically investigate the role of toll-like receptors in these interactions.
Main Methods:
- Literature review of antifungal pharmacotherapy.
- Analysis of studies investigating antifungal drug interactions with innate immunity.
- Focus on toll-like receptor (TLR) signaling pathways.
Main Results:
- Amphotericin B (AmB) remains a primary treatment but has significant side effects.
- Echinocandins offer an alternative to AmB with better tolerability.
- Azoles, like fluconazole and voriconazole, are widely used due to oral availability.
Conclusions:
- Understanding antifungal-innate immune interactions is crucial for developing improved therapies.
- Toll-like receptors are key mediators in the host's response to fungal pathogens and antifungal drugs.
- Combined approaches stimulating the immune response alongside pharmacotherapy show promise.
Related Concept Videos
Antifungal Agents
Inhibitors of Viral Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Fungal Phylum Microsporidia
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Transduction

